Their role in AD is of particular interest because dominant inherited mutations in the catalytic subunits (presenilin (PSEN)1 and PSEN2) of these enzymes are sufficient to cause the full neuropathological and clinical spectrum of this brain disorder. This evidence concerns the gene PSEN1 and Alzheimer disease.